Innovations for the Future of Retail – New Concepts and Technologies
-
Conzoom Solutions – Industry hub of the consumer goods fairs at Messe Frankfurt – encouraging retailers to embrace trends and actively shape the future of shopping.
-
New technologies, innovative concepts, and the targeted emotional engagement of customers are key success factors for the retail of the future.
-
Conzoom Solutions prepares retail for the future with up-to-date industry news, inspiration, insights, and expert contributions.
(Frankfurt, Germany) "Anyone who wants to keep up with technological change and benefit from it must act with foresight and have the drive to implement new opportunities. The future of shopping is already underway and is evolving ever faster through continuous technological impulses," summarises Silke Pfeiffer, Director Multimedia und Data Consumer Goods Fairs at Messe Frankfurt, reflecting on expert statements on the industry portal Conzoom Solutions. On the industry hub of the consumer goods fairs at Messe Frankfurt, experts provide valuable insights into the trends, technologies, and concepts that are revolutionising modern retail – as in an increasingly digitalised world, online and offline experiences are merging ever more strongly.
This includes hybrid shopping behaviours as well as innovative retail concepts that combine technology and creativity – such as Future Retail Stores, Concept Stores, Augmented Reality (AR), or the Metaverse. As interactive formats have an impact on various levels and engage customers in multiple ways, a deep understanding of buying behaviour, decision-making processes, and emotional attachment is essential for forward-thinking retailers.
New technologies and visionary concepts
The Future Retail Store format combines physical presence with innovative technologies, offering retailers new opportunities for product presentation. Customers can discover a wide variety of products and variations, explore them interactively, and try them on individually. (…)
Continue reading...
Pressagency: euromarcom public relations GmbH, team@euromarcom.de, www.euromarcom.de, LinkedIn
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
About Conzoom Solutions
Conzoom Solutions is the industry hub of the consumer goods fairs at Messe Frankfurt, specifically for the international consumer goods trade. It provides the latest news on the consumer goods market, insights from experts, as well as trends and product presentations. As an industry partner for retail, Conzoom Solutions offers an overview of industry events, connections to international manufacturers, and information on ordering options.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom